Maximising Impact: Prof Sir Tony Kouzarides' Lessons from a Career in Research & Start-ups
Join us for an inspiring evening with Prof Sir Tony Kouzarides, a world-renowned cancer and epigenetics researcher, and founder of several pioneering organisations:
Abcam – antibody company (acq. $5.6B)
Storm Therapeutics – clinical-stage first-in-class drug discovery company
Chroma Therapeutics – drug discovery vehicles
Milner Therapeutics Institute – bridging academia, start-ups, biotechs, and pharma
Vellos – venture builder founded to support UK scientists to build world-changing companies
Sir Tony will share personal lessons on ‘Maximising Impact’, drawing on his career at the intersection of science, entrepreneurship, and translational success.
---
6PM - Talk
7PM - Pizza + Networking Reception
---
This event is co-hosted by the Crick Science Entrepreneur Network and early-stage venture firm, Fifty Years.
The Crick Science Entrepreneur Network (CSEN) are a diverse team of PhD students, postdocs, academic and industry professionals, and entrepreneurs, dedicated to promoting and fostering entrepreneurship within the scientific community. CSEN unites researchers at all career stages with a wide range of events, competitions, and activities, which provide scientists with insights into the potential translation of their research and guides their engagement with innovation and start-ups in the field of life sciences.
At Fifty Years, the team have built deep tech companies themselves and published the Spinout Playbook, the ultimate guide to spin out of academia. Fifty Years have backed over 100 deep tech startups and helped them raise over $4.6B.
Everything the the 50Y team knows about deep tech entrepreneurship has been distilled into 5050, a free, 14-week programme to help great scientists and engineers become great founders. Register your interest for the next cohort, kicking off in September 2025.
Powered by the Advanced Research and Invention Agency (ARIA). Check out our privacy policy here.